Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Monica De Leo"'
Autor:
David M. Sherer, MD, Maryam Choudharry, MD, Monica De León-Perazza, MD, Aleksandra Zigalo, RDMS, Mila Kheyman, RDMS, Mudar Dalloul, MD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 2, Pp 661-664 (2024)
The tricuspid valve positioned between the right atrium and right ventricle is composed of 3 leaflets (anterior, posterior, and septal) anchored by a collagenous fibrous annulus, a saddle-shaped, oval structure, providing a firm yet dynamic structura
Externí odkaz:
https://doaj.org/article/caa988c91f874a58be37119c00f35cee
Publikováno v:
Endocrine Reviews. 36:385-486
Cushing's disease (CD), or pituitary-dependent Cushing's syndrome, is a severe endocrine disease caused by a corticotroph pituitary tumor and associated with increased morbidity and mortality. The first-line treatment for CD is pituitary surgery, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a91ba911c0d64c305729e26acbce434
https://doi.org/10.1210/er.2013-1048
https://doi.org/10.1210/er.2013-1048
Autor:
Davide Iacuaniello, Roberta Patalano, Monica De Leo, Annamaria Colpo, Francesca Vitulli, Mariarosaria Negri, L. M. Cavallo, Paolo Cappabianca, Domenico Solari, Claudia Pivonello, Donatella Paola Provvisiero, Rosario Pivonello
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fd7125ad07ad766bdbdd59064e0660e
https://doi.org/10.1530/endoabs.49.ep927
https://doi.org/10.1530/endoabs.49.ep927
Publikováno v:
Expert Opinion on Orphan Drugs. 1:557-567
Introduction: Pasireotide, a novel multireceptor targeted somatostatin analog is the first drug approved for treatment of adult patients with Cushing's disease (CD) for whom pituitary surgery is not an option or has not been curative. Areas covered:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6be1ddcb7fbf9fe71a2c40eec245e76
https://doi.org/10.1517/21678707.2013.807731
https://doi.org/10.1517/21678707.2013.807731
Autor:
Rosario, Pivonello, Maria Cristina, De Martino, Davide, Iacuaniello, Chiara, Simeoli, Giovanna, Muscogiuri, Francesco, Carlomagno, Monica, De Leo, Alessia, Cozzolino, Annamaria, Colao
Publikováno v:
Frontiers of hormone research. 46
Cushing's syndrome (CS) is a severe chronic and systemic condition caused by endogenous or exogenous excess of glucocorticoids, associated with increased morbidity and mortality. Patients with active CS suffer from many metabolic alterations, includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae212cd961829f9b56a2745d926a267e
https://pubmed.ncbi.nlm.nih.gov/27212264
https://pubmed.ncbi.nlm.nih.gov/27212264
Autor:
Maria Cristina De Martino, Monica De Leo, Sossio Cirillo, Chiara Simeoli, Rosario Pivonello, Fabio Tortora, Ciro Mainolfi, Riccardo Rossi, Annamaria Colao, Claudia Pivonello, Renata S. Auriemma, Davide Iacuaniello, Alessia Cozzolino
Publikováno v:
Endocrine. 53(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2803ebeecd47b9db78d9007af6fd5ef7
https://pubmed.ncbi.nlm.nih.gov/25743263
https://pubmed.ncbi.nlm.nih.gov/25743263
Autor:
Giovanna Muscogiuri, Monica De Leo, Annamaria Colao, Alessia Cozzolino, Chiara Simeoli, Francesco Carlomagno, Davide Iacuaniello, Maria Cristina De Martino, Rosario Pivonello
Cushing's syndrome (CS) is a severe chronic and systemic condition caused by endogenous or exogenous excess of glucocorticoids, associated with increased morbidity and mortality. Patients with active CS suffer from many metabolic alterations, includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1095ec01380a4194e7158466057cf13a
http://hdl.handle.net/11588/646643
http://hdl.handle.net/11588/646643
Cushing's syndrome is caused by prolonged exposure to elevated cortisol levels. The most common form of endogenous Cushing's syndrome is Cushing's disease, which results from an adrenocorticotropic hormone-secreting pituitary tumour. Cushing's diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d45ee141a1b60f931af9c5aef19b1ec
http://hdl.handle.net/11588/646647
http://hdl.handle.net/11588/646647
Autor:
Annamaria Colao, Gaetano Lombardi, Maria Cristina De Martino, Alessia Cozzolino, Monica De Leo, Pasquale Vitale, Rosario Pivonello, Chiara Simeoli
Publikováno v:
Neuroendocrinology. 92:77-81
Cushing’s syndrome is commonly complicated with an impairment of glucose metabolism, which is often clinically manifested as diabetes mellitus. The development of diabetes mellitus in Cushing’s syndrome is both a direct and indirect consequence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b26bb66203fa7d80eeea9f24b16ae6f0
https://doi.org/10.1159/000314319
https://doi.org/10.1159/000314319
Autor:
Monica De Leo, Antongiulio Faggiano, Rosario Pivonello, Maria Cristina De Martino, Gaetano Lombardi, Leo J. Hofland, Steven W. J. Lamberts, Paolo Cappabianca, Annamaria Colao
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 94(1), 223-230. Endocrine Society
Background: The role of dopamine agonists in the treatment of Cushing's disease (CD) has been previously debated. Aim: The aim of this study was to evaluate the effectiveness of short-term (3 months) and long-term (12-24 months) treatment with caberg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba0df1774798e1a28145516a29982d57
https://doi.org/10.1210/jc.2008-1533
https://doi.org/10.1210/jc.2008-1533